Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of Disease

By afschroeder • July 10, 2025

Fine SA, Lim SY, Siena NM, de Jesus AB, Goh T, Markus L, Russell TA, Kendal JK, Lofftus SY, Shehata MS, Dao HB, Lee A, Klingbeil KD, Kadera BE, Chmielowski B, Nelson SD, Dry SM, Bernthal NM, Singh AS, Reddy VK, Kalbasi A, Wessel LE, Prins RM, Eilber FR, Eilber FC, McCaw TR, Crompton JG. Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of Disease. J Surg Oncol. 2025 Jul 9. doi: 10.1002/jso.70023. Epub ahead of print. PMID: 40631605.

Tags: Hematology/Oncology, hyper‐progression, immunosuppression, myeloid‐derived suppressor cell, oncologic surgery, Publications, regulatory T cell, soft tissue sarcoma, tumor microenvironment

Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint Inhibitors: Adrenal Insufficiency Is Not Always the Culprit

Shabsovich D, Kathuria-Prakash N, Zhang J, Cabral M, Lopez L, Sumal A, Drakaki A. Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint[...]

RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE)

Wong MK, Milhem MM, Sacco JJ, Michels J, In GK, Couselo EM, Schadendorf D, Beasley GM, Niu J, Chmielowski B, Wise-Draper TM, Bowles TL, Tsai[...]

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

Kumaraswamy A, Hu YM, Yates JA, Zhang C, Rodansky E, Khokhani D, Flores D, Duan Z, Zhang Y, Tabatabaei S, Slottke R, Ye S, Lara[...]